ERECTILE - 35 Annonces

Tuesday 09 December 2025

Quantité : 500kg/mont - Prix : FOB

Extrait de Ginseng (Free-pesticides) Améliorer la mémoire et renforcer le système immunitaire ㄳ ㅋ anti-fatigue et anti-vieillissement Extrait de Ginseng est extrait de Panax Ginseng CAMey par de l'éthanol et de l'eau. Partie utilisée: racine, feuilles et tige Avantage: 1. Améliorer...

Friday 29 August 2025

PT-141 was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. It activates melanocortin receptors. PT-141 is used for the treatment of erectile dysfunction in men and for the treatment of hypoactive ual desire disorder in women...

Wednesday 20 August 2025

PT-141 was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. It activates melanocortin receptors. PT-141 is used for the treatment of erectile dysfunction in men and for the treatment of hypoactive ual desire disorder in women...

Friday 01 August 2025

PT-141 was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. It activates melanocortin receptors. PT-141 is used for the treatment of erectile dysfunction in men and for the treatment of hypoactive ual desire disorder in women...

Tuesday 15 July 2025

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998,...

Tuesday 15 July 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Wednesday 09 July 2025

PT-141 was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. It activates melanocortin receptors. PT-141 is used for the treatment of erectile dysfunction in men and for the treatment of hypoactive ual desire disorder in women...

Tuesday 08 July 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Friday 04 July 2025

PT-141 was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. It activates melanocortin receptors. PT-141 is used for the treatment of erectile dysfunction in men and for the treatment of hypoactive ual desire disorder in women...

Thursday 03 July 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Friday 27 June 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Wednesday 25 June 2025

PT-141 was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. It activates melanocortin receptors. PT-141 is used for the treatment of erectile dysfunction in men and for the treatment of hypoactive ual desire disorder in women...

Tuesday 10 June 2025

Quantité : 1kg; 25kg;

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998, the...

Saturday 07 June 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Friday 06 June 2025

Quantité : 1kg; 25kg;

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Friday 16 May 2025

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998, the...

Friday 16 May 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Friday 25 April 2025

Quantité : 9999 - Prix : 1,00 €

PT-141 was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. It activates melanocortin receptors. PT-141 is used for the treatment of erectile dysfunction in men and for the treatment of hypoactive ual desire disorder in women...

Tuesday 22 April 2025

PT-141 was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. It activates melanocortin receptors. PT-141 is used for the treatment of erectile dysfunction in men and for the treatment of hypoactive ual desire disorder in women...

Wednesday 16 April 2025

PT-141 was approved by the FDA in June 2019 for the treatment of acquired, generalized HSDD in premenopausal women. It activates melanocortin receptors. PT-141 is used for the treatment of erectile dysfunction in men and for the treatment of hypoactive ual desire disorder in women...

Tuesday 08 April 2025

Quantité : 9999 - Prix : 1,00 €

Mixed testosterone relieves all low testosterone problems (low drive, low confidence, erectile dysfunction, lower muscle mass, weak muscle strength) Localisation : No. 10-11, Building 4, Zhongyu Duhui First Station, Longxi Street, Yubei District, Chongqing, 400020 Yubei District,...

Tuesday 08 April 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Tuesday 08 April 2025

Quantité : 9999 - Prix : 1,00 €

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998, the...

Thursday 03 April 2025

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998, the...

Thursday 03 April 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Saturday 29 March 2025

The introduction of the oral phosphodiesterase type 5 (PDE5) inhibitor sildenafil citrate (trade name: ) opened a new chapter in the history of erectile dysfunction (ED) treatment. Since Sildenafil citrate was approved by the US Food and Drug Administration (FDA) in March 1998, the...

Wednesday 19 March 2025

Tadalafil (market name “Cialis” or “Adcirca”) was developed by American pharmaceutical company Lilly. It is a kind of PDE5 inhibitor used for the treatment of erectile dysfunction, benign prostatic hypertrophy and pulmonary arterial hypertension.The effect of Tadalafil is relaxing...

Wednesday 31 January 2024

Quantité : 1 Piece (M) - Prix : US $1,850.00-2,550.

- Basic Info. - Model NO. QM-SW10 EMS Energy 1 - 20 Heads Size 20/40/60mm Function Body Massage / ED Treatment Frequency 1-16Hz EMS Frequency 1-30 Shockwave Energy 5-200mj RF Frequency 300-450kHz Package 513*505*455mm Transport Package Aluminum Box Specification Facial Care Trademark...

Wednesday 31 January 2024

Quantité : 1 Piece (M) - Prix : US $1,350.00-1,850.0

- Basic Info. - Model NO. QM-SW9+ After-Sale Service Online Technical Support Massage Area Fully Body Function Body Massage / ED Treatment Frequency 1-16Hz Color White Power 200W Screen 8 Inch Touch Screen Warranty 2 Years Transport Package Aluminum Box Specification Facial Care...

Wednesday 31 January 2024

Quantité : 1 Piece (M) - Prix : US $700.00-1,200.00

Basic Info. Model NO. QM-SW8 After-Sale Service Online Technical Support Massage Area Fully Body Function Body Massage / ED Treatment Frequency 1-16Hz Color White Power 200W Screen 8 Inch Touch Screen Warranty 2 Years Transport Package Aluminum Box Specification Facial Care Trademark...